Cellbox Solutions

Transporting live cells under perfect laboratory conditions just became even more seamless for the regulatory pathway. The technical data (DMF) for the technology of all our Cellbox™ has been filed with the FDA, meaning our full portfolio is now ready for clinical studies. What this means for our Cell & Gene Therapy partners: ⚡ Accelerated Approvals: Seamlessly cross-reference our file in your submissions. 📉 Zero Friction: Eliminate redundant paperwork and speed up your clinical trial timelines. #CellboxSolutions #WarmChainLogistics #FDACompliance #CellTherapy #ClinicalTrials #Biotech

🧬 Clinical Trials Day highlights how fast Cell & Gene Therapy is evolving. But as therapies scale across sites and borders, another challenge becomes increasingly important: infrastructure. How do we move living materials without compromising functionality along the way? ▶️ At Meeting on the Med in Rome, our CFO/CBO Dr. Bernd Mühlenweg spoke with Onyx about warm chain transport, controlled live cell logistics, and the future scalability of advanced therapies. We recently explored these challenges further here: cellbox-solutions.com/cell-transport… #cellandgenetherapy #clinicaltrialsday #advancedtherapies

#articleoftheweek Cells do not function in isolation. Their environment matters. A new Nature Biomedical Engineering study mapped how human bone marrow mesenchymal stromal cells are positioned within their native niche and how this changes with age. A reminder that biological quality is shaped long before any readout begins. If cellular context matters inside the body, should it matter more across the workflow? 🔗 nature.com/articles/s4155… #stemcells #regenerativemedicine

This becomes critical in space-related research using organoids.

Cells don’t “pause” during transport. Their state before the experiment already shapes the outcome. #organoids #spaceresearch

Not everything that changes in microgravity is caused by microgravity. (parabolic flight experiment, Beghin & Greni Lab, Mechanobiology Institute, NUS)

Advances in healthcare rely on reliable biology. But variability does not start in the lab. Handling, packaging, and transport already influence cellular behavior and downstream results. Reproducibility begins before the experiment. #cellculture #biotech #worldhealthday #cellbox

Not every lab delivery arrives by standard courier. But safe transport for living cells always matters. Happy Easter from Cellbox Solutions.🐇 Learn more about live cell transport here: youtube.com/watch?v=r9ePxo… #celltransport #biotech #cellbox

We’ve closed the first tranche of our Series A financing round, raising ~€3.5M led by @Companisto together with existing investors, including NRW.BANK. The funding will accelerate the global expansion of our warm-chain logistics platform for transporting living cells and new applications in life sciences. We’re also excited to welcome Dr. Bernd Muehlenweg as Chief Business Officer & Chief Financial Officer. Read the full press release here: cellbox-solutions.com/news/cellbox-s…

When environmental control and usability come together, cell logistics becomes more predictable and scalable across facilities. #celltransport #reproducibility

🧫 Modern cell transport requires more than environmental control. Practical usability and seamless workflow integration are becoming essential for predictable and scalable research operations across sites. #celltransport #reproducibility #lifescience

New year. New beginnings. Wishing everyone celebrating a joyful Lunar New Year ✨ #LunarNewYear

As cell therapies scale globally, manufacturing and logistics are becoming biologically relevant variables rather than purely operational ones. This work, developed together with Fraunhofer, highlights how transport conditions can shape downstream cell therapy performance. Worth a closer look. Link: doi.org/10.3389/fbioe.…

NK cell therapies are moving closer to routine clinical use, but logistics remain an underestimated variable. Comparative data suggest cryopreservation can reduce viability and functional cytotoxicity compared to controlled live transport conditions, highlighting how handling can directly influence therapeutic cell quality.

A concise and worthwhile read for researchers working in stem cells, organoids, and translational immunology. ➡️ rdcu.be/e3GB9

This could strengthen future cell-based immunotherapies and improve reliability of iPSC-derived immune cell manufacturing.

#ArticleoftheWeek A recent study in Nature Communications by Tsutsui et al. introduces a 3D organoid-based artificial thymus to improve generation of functional iPSC-derived immune cells. Another strong contribution from Kyoto’s iPSC ecosystem. Thread 👇

Learn about critical safety precautions including CO₂ handling, battery safety and transport best practices when operating the Cellbox™ Go. Episode 2 of our Cellbox™ Go Training Series is now available on YouTube 🎬🧪 Watch here 👉 youtube.com/watch?v=I7dLZ1… #celltherapy #atmp #biotech #lifesciences #celltransport